← Open Payments lookup

ASHLEE SPARKS: Open Payments

NPI 1841905007 · BELLMEAD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,339 in 78 payments from 19 companies in 2025. Trend: 2023 $1,040 · 2024 $1,209 · 2025 $1,339

Food & beverage: $1,339
CompanyPaymentsAmount
ABBVIE INC.20$290
Sumitomo Pharma America, Inc.2$188
Novo Nordisk Inc8$149
AstraZeneca Pharmaceuticals LP7$131
Lilly USA, LLC6$96
Phathom Pharmaceuticals, Inc.11$76
Boehringer Ingelheim Pharmaceuticals, Inc.4$73
GlaxoSmithKline, LLC.3$51
Exact Sciences Corporation3$48
Kowa Pharmaceuticals America, Inc.3$46

Products named: GEMTESA, UBRELVY, JARDIANCE, MOUNJARO, VOQUEZNA, QULIPTA, FARXIGA, VRAYLAR.

Industry payments across TX — which companies pay providers there.